Cargando…
Effect of Spironolactone in Resistant Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial (ASPIRANT-EXT)
This study was designed to assess the effect of the addition of low-dose spironolactone on blood pressure (BP) in patients with resistant arterial hypertension. Patients with office systolic blood pressure (SBP) >140 mm Hg or diastolic blood pressure (DBP) >90 mm Hg despite treatment with at l...
Autores principales: | Václavík, Jan, Sedlák, Richard, Jarkovský, Jiří, Kociánová, Eva, Táborský, Miloš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602792/ https://www.ncbi.nlm.nih.gov/pubmed/25501057 http://dx.doi.org/10.1097/MD.0000000000000162 |
Ejemplares similares
-
Acupuncture treatment of hypertension with insomnia: A protocol for randomized, double-blind, placebo controlled trial research
por: Zhu, Xun, et al.
Publicado: (2022) -
Spironolactone is superior to hydrochlorothiazide for blood pressure control and arterial stiffness improvement: A prospective study
por: Liu, Yan, et al.
Publicado: (2018) -
Improvement of Shen’ge formula on heart function in diastolic heart failure: A protocol for randomized, double-blind, placebo-controlled clinical study
por: Qiu, Boyong, et al.
Publicado: (2021) -
Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial
por: Yang, Guang, et al.
Publicado: (2020) -
Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial
por: An, Su, et al.
Publicado: (2021)